<?xml version="1.0" encoding="UTF-8"?>
<ref id="B95-medicina-57-00217">
 <label>95.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Li</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Yuan</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Deng</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>Tang</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Yu</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Xu</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>Zou</surname>
    <given-names>Y.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Safety and efficacy of artemisinin-piperaquine for treatment of COVID-19: An open-label, non-randomized, and controlled trial</article-title>
  <source>Int J. Antimicrob. Agents</source>
  <year>2020</year>
  <volume>18</volume>
  <fpage>106216</fpage>
  <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2020.106216</pub-id>
  <?supplied-pmid 33152450?>
  <pub-id pub-id-type="pmid">33152450</pub-id>
 </element-citation>
</ref>
